PC-FACS
PCFACS Home | Issues | Advanced Search |
November 15
Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited. |
Chee KF, Nguyen DV, Brown M, Gandara DR, Wun T, Lara PN Jr. |
Positron Emission Tomography and Improved Survival in Patients With Lung Cancer Background: Has the sensitivity of positron emission tomography (PET) scanning in nonâ??small cell lung cancer ha... |
>> Continue Reading |
Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. |
Temel ST, McCannon J, Freer JA, et al. |
Aggressiveness of Care in a Prospective Cohort of Patients With Advanced NSCLC Background: How aggressive is care provided to patients diagnosed with advanced nonâ??small cell lung cancer (NSCL... |
>> Continue Reading |
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioids-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-canc |
Webster L, Jansen JP, Peppin J, et al. |
Alvimopan, A Peripherally Acting Mu-Opioid Receptor (PAM-OR) Antagonist for the Treatment of Opioids-Induced Bowel Dysfunction Background: Can a peripherally acting mu-opiod receptor (PAM-OR) antagon... |
>> Continue Reading |
Self-reported napping and duration and quality of sleep in the lifestyle interventions and independence for elders pilot study. |
Picarsic JL, Glynn NW, Taylor CA, et al. |
Napping and Nocturnal Sleep in Older Adult Background: It is common to advise patients to avoid napping to improve nighttime sleep. Does napping affect the objective and subjective quality of nocturn... |
>> Continue Reading |
PCFACS Home | Issues | Advanced Search |
For questions regarding this publication, send an email to resources@aahpm.org or call 847/375-4712.